{
    "2018-05-25": [
        [
            {
                "time": "2018-01-03",
                "original_text": "U.S. jury fails to reach verdict in latest J&J talc trial",
                "features": {
                    "keywords": [
                        "jury",
                        "verdict",
                        "J&J",
                        "talc",
                        "trial"
                    ],
                    "sentiment_score": -0.4,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "none"
                }
            },
            {
                "time": "2018-01-03",
                "original_text": "No Verdict Reached in J&J Baby Powder Case",
                "features": {
                    "keywords": [
                        "verdict",
                        "J&J",
                        "Baby Powder",
                        "case"
                    ],
                    "sentiment_score": -0.3,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "none"
                }
            },
            {
                "time": "2018-01-03",
                "original_text": "A Focus on Eye Care Is Setting Up Johnson & Johnson Stock for the Future",
                "features": {
                    "keywords": [
                        "Eye Care",
                        "Johnson & Johnson",
                        "Stock",
                        "Future"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-01-03",
                "original_text": "Dow 30 Stock Roundup: GE's Transportation Unit to Merge With Wabtec, J&J & Glaxo's HIV Drug Gets EU Approval",
                "features": {
                    "keywords": [
                        "Dow",
                        "GE",
                        "Transportation",
                        "Wabtec",
                        "J&J",
                        "Glaxo",
                        "HIV Drug",
                        "EU Approval"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "industrial",
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-01-03",
                "original_text": "AbbVie's Imbruvica's Phase III Study Meets Primary Endpoint",
                "features": {
                    "keywords": [
                        "AbbVie",
                        "Imbruvica",
                        "Phase III",
                        "Study",
                        "Primary Endpoint"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-01-03",
                "original_text": "3 Likely Reasons Geron Stock Is Sizzling Hot Right Now",
                "features": {
                    "keywords": [
                        "Geron",
                        "Stock",
                        "Sizzling Hot"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "biotech"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-01-03",
                "original_text": "What Is Geron Corporation's Downside Risk?",
                "features": {
                    "keywords": [
                        "Geron Corporation",
                        "Downside Risk"
                    ],
                    "sentiment_score": -0.5,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "biotech"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2018-01-03",
                "original_text": "J&J Jury Asks Judge to Slap Cancer Warning on Baby Powder",
                "features": {
                    "keywords": [
                        "J&J",
                        "Jury",
                        "Cancer Warning",
                        "Baby Powder"
                    ],
                    "sentiment_score": -0.7,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            }
        ]
    ]
}